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ABSTRACT
A drug resistance survey involving Mycobacterium tuberculosis isolated from patients 
of a tertiary Hospital in the Rio de Janeiro city (RJ), Brazil, between the years 1996 and 
1998 revealed a high frequency of isoniazid (HR) resistance. These isolates were revisited 
and genotyped. Patients came from different RJ neighborhoods and municipalities, and 70% 
were outpatients. Applying the 3’ and 5’ IS6110-RFLP and the Spoligotype genotyping 
methods, the clonal structure of this population was investigated obtaining a snapshot of 
past epidemiological events. The 3’ clusters were subsequently 5’ IS6110-RFLP typed. 
Spoligotyping was analyzed in the SITVIT2 database. Epidemiological relationships were 
investigated. The major lineage was T (54.4%), and SIT 53/T1 and SIT 535/T1 were the most 
frequent. The T1 sublineage comprises 12.8% of resistant strains and SIT 535 were assigned 
for 31.8% of them. Orphan patterns corresponded to 12% and 73.3% and belonged to the 
T lineage. One pattern was unlisted in the SITVIT2. The 5’ IS6110-RFLP did not confirm 
3/12 of the 3’ IS6110-RFLP clusters. A combination of all methods decreased the number 
of clusters to three. Nosocomial transmission was associated with one cluster involving a 
hospital cupbearer. This event was suspected in a multidrug resistant-TB inpatient caregiver 
who harbored a mixed infection. The 3’ IS6110 clusters were associated with HR (p=0.046). 
These genotypic retrospective data may reflect a fraction of more extensive recent transmission 
in different communities that may be corroborated by the concentration of HR patients, and 
may serve as a database for further evolutionary and characterization evaluation of circulating 
strains and together with epidemiological data favors a more effective transmission control.
KEYWORDS: Tuberculosis. Mycobacterium tuberculosis. 3’-5’ IS 6110 RFLP. Mixed 
infection. Nosocomial transmission.
INTRODUCTION
Tuberculosis (TB) is an airborne-transmitted disease with an estimated 
10.0 million (range, 9.0–11.1 million) new cases worldwide and 1.3 million 
deaths occurring in 2017. Brazil, with 91,000 notifications, ranks 19th among 
30 high-burden countries and contributes with 33% of the total cases in the 
Americas1,2. Currently, the Rio de Janeiro State, with high population density rates 
(≈5,265.82 inhabitants/km2), presents a TB incidence of 63.5/100.000 inhabitants 
(inh). Regrettably, this is higher in the Rio de Janeiro city (RJ) (85.5/100.000 inh.), 
ranking second in the country, presenting the highest death rate (4.4/100.000 inh.)3,4. 
However, in 1995, this State was ranked in the same position, with a high percentage 
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of TB retreatment5 and with one-third of TB cases being 
reported in hospitals6. A survey carried out from 1996 to 
1998 at the Pedro Ernesto University Hospital (HUPE), 
which, as a tertiary health service received patients from 
different geographic areas of RJ, indicated an isoniazid-
resistant M. tuberculosis rate of 13%5. 
Genotyping methods, such as spoligotyping and RFLP, 
are performed to understand TB transmission. These 
routine approaches are used in several developed countries, 
while molecular studies are punctual in developing 
countries and usually only one genotyping method is used. 
Spoligotyping is less powerful for cluster investigations 
than IS6110-RFLP. Nevertheless, if strains are isolated 
from patients coming from different geographic areas, 
cluster definition failures may occur, as the restriction sites 
may be located in different points throughout the IS6110 
sequence on the bacterial genome. This is due to genetic 
mechanisms that can lead to loss of the restriction site 
flanking the IS6110 insertion, compromising case grouping. 
An alternative method that increases the probability of 
grouped strains actually being related clones, especially if 
strains are isolated from unrelated geographic areas, has 
been described using the 5’ IS6110 probe7. Briefly, the 
physical IS 6110 map indicates a single Pvu II restriction 
site that has been successfully applied to the cleavage of 
these sequences in order to obtain two IS 6110 restriction 
fragments of different sizes, reflecting polymorphisms 
between strains. The right side of the Pvu II restriction site 
was arbitrarily chosen for the standardization of RFLP 
genotyping by reducing the number of IS6110 fragments to 
the half. In some cases, for a better differentiation between 
strain patterns, membranes could be re-hybridized with 
labeled DNA probes containing only of the IS6110 fragment 
on the left of the Pvu II restriction site8 (Figure 1). On the 
other hand, the RFLP-IS6110, despite being more laborious 
than the MIRU-VNTR, a PCR based method using 12 or 
24 interspaced markers, or spoligotyping, requiring higher 
amounts of DNA, has the advantage of a strong genetic 
stability, which makes this technique appropriate to identify 
true clusters in old population strains9.
In the present study, taking the advantage of data 
availability and isolates from HUPE patients, a retrospective 
cluster investigation by 3’ - 5’ IS6110- RFLP is reported, 
using the same membrane and the spoligotyping scenario 
on phylogenetic diversity. Clusters defined by all methods 
and the investigated epidemiological relationships provided 
a snapshot of past epidemiological events.
MATERIAL AND METHODS
Study site, patients and M. tuberculosis isolates
Despite its location in the Vila Isabel neighborhood, 
in the Rio de Janeiro city, HUPE receives patients from 
several other municipalities, as well as other States, since it 
is a referral center for AIDS treatment, as well as for many 
primary and secondary health care units. From August 1996 
to February 1998, the hospital had 604 beds and presented 
an estimated 350 TB cases diagnosed per year. However, the 
hospital presented no respiratory isolation beds and no TB 
control actions5. A total of 415 isolates from 248 patients 
identified in the previous study, were subcultured in 
Löwenstein Jensen’s medium (LJ) and 125 growths (30.1%) 
from 106 (43%) patients from different neighborhoods and 
municipalities in Rio de Janeiro were obtained. Multiple 
isolates (36/125) were obtained from 17 patients (Figure 2). 
Most of these patients harbored two isolates, except for 
two, which presented three isolates each. Of the total 
number of isolates, 70% belonged to outpatients, while the 
remaining patients spent an average of 14.6 ± 13.1 days 
in the hospital. Most individuals sought HUPE care with 
suspected pulmonary TB (83%). 
Previously, biochemical tests, (positive niacin 
production, positive nitrate reductase activity and negative 
catalase thermal-inactivation), identified the M. tuberculosis 
complex (MTBC), while drug susceptibility testing (DST) 
to isoniazide (H), rifampicin (R), pyrazinamide (Z), 
streptomycin (S), ethambutol (Eb) and ethionamide (Et) was 
performed by the standard proportion method in LJ medium, 
at the Central Noel Nutels Laboratory (LACENN), RJ10. 
Socio-demographic, clinical and laboratory data analyses 
were carried out by assessing the patients’ medical records. 
No contact or personal interviews were performed with 
patients to obtain additional information. This study was 
approved by the HUPE Research Ethics Committee. 
Molecular typing 
CTAB-DNA based extraction was performed11 in 113 
isolates from 95 patients, while thermolysis extraction 
was carried out for the remaining isolates12. Spoligotyping 
Figure 1 - Schematic representation of the 6110 insertion 
sequence (IS), present in the Mycobacterium tuberculosis 
genome, cleaved by the Pvu II endonuclease yielding two 
fragments8 used as probes in restriction fragment length 
polymorphism 3’ IS6110 and 5’ IS6110 genotyping studies.
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follow the Kamerbeek et al.13 protocol, using spoligo-
membranes from Ocimum Biosolutions Ltda (Hyderabad, 
India). An overestimation of the number of potentially 
related isolates is a possibility, as the discriminatory 
power of spoligotyping is lower and patients were from 
unrelated communities. Thus, 3’ IS6110-RFLP-based 
typing was applied. The clusters obtained by this method 
were also 5’ IS6110-RFLP typed. The 3’ IS6110-RFLP 
technique was carried out as previously described8,14. 
The 5’ IS6110-RFLP method was performed as described 
elsewhere15,16, with minor modifications. Briefly, probe 
hybridization was carried out on the same 3’ IS6110 assayed 
membranes after removal of the precipitated blue color 
and the 3’ probe by heating the membranes at 50-60 ºC 
in pure dimethylformamide (Dig nucleic acid detection 
kit, Roche, USA). The positive and negative controls for 
each experiment were the ATCC 14323 M. tuberculosis 
and an M. avium clinical isolate, respectively. Laboratory 
cross-contamination was ruled out through verification 
that isolates with an identical fingerprint pattern had not 
been processed on the same day. To avoid risks of cross-
contamination during cultivation and preparation of clinical 
samples for genotyping, all sample processing took place 
in laminar flow cabinets and only a limited number of 
specimens were processed on the same day.
Data analyses
Spoligotyping patterns were documented as octal and 
binary codes and compared to the SITVIT2 proprietary 
database17 an updated version of the SITVITWEB 
database18. The Spoligotype International Type (SIT) 
classification designates identical patterns shared with 
at least one other profile present in the database, while 
“orphan” patterns are applied for a single isolate that does 
not present any homology among patterns recorded in the 
Figure 2 - Flowchart on the recovery of M. tuberculosis isolates of TB patients attended at the tertiary Pedro Ernesto University 
Hospital, Rio de Janeiro, Brazil, 1996-1998, and the main genotyping results.
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repository database. New spoligo patterns, whether orphan 
or encountered in multiple isolates in the present population, 
were repeated. Phylogenetic lineage identification was 
according to the signature provided by the database, defining 
62 genetic lineages/sublineages. Georeferenced data 
allowed the identification of the geographic location of the 
spoligopatterns, as well as of true-clustered patients, through 
the home address of each patient (Figure 3). Spoligotypes 
and 3’ and 5’ IS6110-RFLP patterns were analyzed by 
the Bionumerics 5.3 (Applied Maths, NV, Sint-Martens-
Latem, Belgium) and/or GelCompar 3.1 (Applied Maths, 
Kortrijk, Belgium) softwares and supplemented visually. 
Cluster definition was two or more patients infected with 
M. tuberculosis harboring the same genotype obtained by the 
spoligotyping and 3’ IS6110 methods. However, true clusters 
were assigned to those with the same genotype patterns 
Figure 3 - Espatial georeferenced distribution of genotyped M. tuberculosis strains isolated from patients attended at the Pedro 
Ernesto University Hospital in Rio de Janeiro, Brazil, 1996-1998: A) Rio de Janeiro State; B) true clustered patients defined by 
3’ – 5’ IS 6110-RFLP and spoligotype, and orphans spoligopaterns; C) Rio de Janeiro city.
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combining all three methods, followed by epidemiological 
link assessments. Statistical significance between categorical 
variables was Chi-square estimated by Yates correction 
and an odds ratio at a 95% confidence interval, in order to 
establish associations among the clustered patients. The 
discriminatory power of 3’ RFLP IS 6110 was calculated 
by applying the numeric discriminatory index (HGDI), as 
suggested by Hunter and Gaston19.
RESULTS
The spoligotyping method distributed the isolates into 
six lineages and 16 sub-lineages, as displayed in Figure 4. 
Most belonged to the ill-defined T spoligotype (68/125, 
54.4 %), which predominates in different Rio de Janeiro 
neighborhoods, including 73 % of the orphan SIT patterns. 
The H and LAM, X, S and Manu2 lineages were less 
frequent (≥12.8 %). Surprisingly, the usually low banding 
X clade presented two strains with higher copy numbers 
(> 10). One new spoligopattern signature (0.8%) was 
identified. Four new shared types resulting from this study 
were created in the database, SIT1906 (LAM6), SIT1907 
(Ud), SIT1909 (T1) and SIT1911 (T3). Different SITs 
(n=43) and 88/125 (70.4%) isolates belonged to 23 groups. 
The largest genetic group comprised 15 isolates of the 
ubiquitous SIT53 (17%), followed by 10 isolates presenting 
Asian or African spoligotype (11.4%), belonging to the 
T1 sub-lineage, which also predominated in six other 
genetic groups from two patients. It is noteworthy that 
most of drug-resistant isolates were from the T1 lineage 
Figure 4 - Spoligotype patterns and number of shared international typing (SIT) of 125 M. tuberculosis strains isolated from 106 
patients attended at the Pedro Ernesto University Hospital, Rio de Janeiro, Brazil, 1996-1998.
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(22/58), with a third (31.8 %) from the SIT 535. Risk 
factors were not identified although most MDR (2/3) and 
multiple resistant (4/6) isolates belonged to the T lineage. 
The remaining MDR were LAM2/SIT179 and belonged 
to a polyclonal infection case. Spoligotyping identified 
polyclonal infections among all 17 TB diagnosed patients 
who displayed multiple sputum isolates. However, the 
RFLP 3’ IS 6110 genotyping confirmed mixed infection 
in only 3/17 patients, including the MDR LAM2/SIT179 
strain (Table 1). It is important to mention that only one 
specimen was processed on the same day as other specimens 
from the study, minimizing the risk of cross contamination.
The 3’ IS6110-RFLP method defined 28/95 (29.5%) 
patients distributed in 11 clusters, most containing two 
patients, except for three clusters, one comprising four 
patients and two, five patients each. No isolates presented 
only one copy number or none. The discriminatory power 
of the 3’ IS 6110-RFLP method was 0.986. The available 
demographic, clinical, and DST characteristics of the 
patients with strains genotyped by the 3’ IS 6110-RFLP 
method are summarized in Table 2. The analysis regarding 
possible risk factors did not identify significant cluster 
associations, except for HR (p = 0.046). 
The 5’ IS6110-RFLP method, performed for 10/11 
clusters from 25 patients and did not confirm three 
3’ IS6110 clusters. One of the clusters containing four 
patients was excluded, while the other clusters comprising 
two patients each were split. Thus, 20 patients distributed 
into eight clusters remained (Table 3, Figure 2). However, 
combining the clusters obtained by spoligotyping, 3’ and 
5’ IS6110-RFLP resulted in a dramatic decrease in cluster 
isolates (n = 6; 6 %), distributed into three true clusters 
with two patients each, one of them characterized as a 
nosocomial transmission event (Figure 2). Among the 
3’ IS6110-RFLP clusters, three were subdivided by the 
5’ IS6110-RFLP method, and only six patients remained 
clustered by spoligotyping. It is interesting to note that, 
among patients with low banding patterns who were all 
clustered by both RFLP probes, only 2/7 remained grouped 
by the spoligotyping method (Table 4). Although both 
patients were infected with resistant strains, no detectable 
evidence of an epidemiological relationship was observed. 
The nosocomial transmission was discovered involving 
two patients with immunosuppression due to chronic 
degenerative diseases. Both presented type II diabetes and 
one suffered from laryngeal cancer and dermatomyositis. 
They live in the same municipality, but in different 
neighborhoods, at a distance of approximately 3.9 km. 
However, both underwent several HUPE hospitalizations 
and, in 1996, they met each other as outpatients undergoing 
treatment in the dermatology service. A 65-year-old patient, 
hospitalized from 6/26/1996 to 10/10/1996, with negative 
smear microscopy and bronchoalveolar lavage culture, aside 
from a radiography showing a pulmonary inflammatory 
infiltrate was discharged with a corticoid prescription. This 
patient returned 5 months later (03/11/1997) presenting 
changes of X-ray images indicative of TB and a positive 
AFB sputum smear, initiating the TB specific treatment but 
Table 1 - Genotypic patterns from Mycobacterium tuberculosis isolates defined by spoligotype and 3’ IS 6110-RFLP and data from 
patients harboring mixed Infections who attended the tertiary Pedro Ernesto Universty Hospital (1996-1998)
Age Sex Unity
Inpatient 
Time 
(days)
Neigborhood/
Municipality
Isolation 
Data DST Spoltype (SIT/Sublineage) 3’ IS6110-RFLP pattern Remarks
29 F PN - Leblon/RJ
10/16/96 MDR  (179/LAM2)
 Caregiver, 
Black, 
BCG scar, 
Born in RJ11/13/96 MDR+EtR
 
(535/T1)
 
30 M PN 9 WI
08/13/96 S  (1163/T1)
 White, 
Sm, born in 
RJ09/13/96 S  (53/T1)
 
15 F DIP 18 Cascadura/RJ
08/01/97 S  (50/H3) ND Student, 
Black, BCG 
scar, born in 
RJ, bronchitis
08/13/97 S  (535/T1)  
09/05/97 S  (Orphan/T1)  
F: female; M: male; PN :pneumology clinic; DIP: infectious diseases parasitic clinic; WI: without information; RJ: Rio de Janeiro; 
DST: drug susceptibility test; EtR: ethionamide resistant; S: susceptible; MDR: resistant at least to isoniazid and rifampicin; N: no; 
BCG: Bacille Calmette Guèrin vaccine scar; Sm: smoker; SIT: sheared international typing; ND: not done.
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dying three months later (06/07/1997). The other patient, 
a HUPE cupbearer employee who also suffered multiple 
hospitalizations in different HUPE wards, presented a 
marked tuberculin skin test and positive AFB sputum smear, 
only 31 days (04/16/1997) after the TB diagnosis of the 
first patient. Patients underwent treatment with TB first line 
drugs and isolates were EtR. 
The other two clusters displayed no special 
epidemiological features and no associations could be 
established, as the patients lived in different neighborhoods 
far from each other (>39 km) (Table 3). No epidemiological 
relationships were found for the remained clusters defined 
by the 3’ RFLP probe.
Concerning the possible mixed infection cases, a 
decrease to three was observed after combining the 
spoligotyping and the 3’ IS6110-RFLP method (Table 1). 
MDR harboring an extra Et resistance were identified in one 
of the isolates. The linked patient was BCG scar positive 
and a TB HUPE inpatient caregiver. The two-sputum exam 
collections were carried out one month apart, and treatment 
was initiated with RHZ after the patient has informed never 
having received treatment for TB. Although this patient may 
have been involved in a nosocomial transmission event, no 
reliable epidemiological relationship could be established, 
since the other patient harboring an isolate with the same 
clonal pattern developed TB 11 months afterwards, was 
fully drug sensitive and reported TB treatment 15 years 
prior to this event. The remaining two polyclonal cases were 
inpatients for at least nine days, living in different Rio de 
Janeiro neighborhoods. Both stated that they had never been 
treated for TB, BCG scars were present and sputum exams 
on different days/months indicated fully drug susceptible 
isolates (Table 1). 
DISCUSSION
Retrospective studies focusing on genotyping pattern 
frequencies provide important data on the relationship 
Table 2 - Clinical, demographic and laboratory features of clustered and no clustered patients of Pedro Ernesto University Hospital 
by 3’ IS 6110-RFLP, from August 1996 to February 1998, Rio de Janeiro, Brazil
 
Features Cluster N = 28 (%)
No cluster 
N = 67 (%)
Odds Ratio (OR) 
(CI-95%) p value
Age as x (DP)1 39.7 (14) 40.5 (11) 1.37 (0.11-15.83) 0.68
Genus 
Male 
Female
 
19 (68) 
9 (32)
 
53 (79) 
14 (21)
 
0.56 (0.2-1.4) 
-
 
0.36 
-
Education Level 
Elementary 
High school 
wi
 
18 (64) 
0 
10 (36)
 
50 (75) 
0 
17 (25)
 
- 
- 
-
 
- 
- 
-
Alcoholism
Yes 
No 
wi
6 (21) 
16(57) 
6 (22)
26 (39) 
30 (45) 
11(16)
0.4 (0.14-1.26) 
1.0 
-
0.19 
 
HIV 
Seropositive 
Seronegative 
wi
 
5 (18) 
11 (39) 
12 (43)
 
20 (30) 
29 (43) 
18 (27)
 
1.51 (0.45-5.04) 
1.0 
-
 
0,69
Pre-treatment 
Yes 
No 
wi
 
2 (7) 
12 (43) 
14 (50)
 
10 (15) 
36 (54) 
21 (31)
 
0.6 (0.11-3.13) 
1.0 
-
 
0.78
Drug susceptibility 
Sensitive 
Any Resistance 
wi
 
9 (32) 
14 (50) 
5 (18)
 
26 (39) 
35 (52) 
6 (9)
 
1.15 (0.43-3.07) 
1.0 
-
 
0.96
Resistance to H 
Resistant 
Sensitive 
wi
 
7 (25) 
16 (57) 
5 (18)
 
6 (9) 
55 (82) 
6 (9)
 
4.01 (1,17-13.64) 
1.0 
-
 
0.046
1average and standard deviation. CI: confidence index; wi: without information; HIV: human immunodeficiency virus; H: isoniazid; 
RFLP: restriction fragment length polymorphism. 
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between risk factors and diseases. Scarce studies using 
spoligotype had been carried out at that time in Brazil so 
that little is known about the most frequent spoligopatterns. 
In addition, few studies using two or more genotyping 
methods to investigate clustered infected TB patients have 
been performed. In the present study, a greater diversity 
of spoligopatterns in the South, North and central zones 
of the city of Rio de Janeiro is noteworthy (Figure 3). The 
T lineage, one of the most prevalent genotypes in Africa, 
Central South and North America and Europe17, was the 
most frequent herein, corresponding to over one third 
(36.6%) of the T1 sublineage (Figure 4). 
Currently, the ubiquitous LAM clade is the major 
circulating lineage in RJ, as described in a study carried out 
in 11 Brazilian States in which RJ contributed with 40% 
of all typed isolates, mainly obtained from hospitals (2000 
to 2005), as well as with 65 % of the LAM family20,21. In 
another study, the predominance of LAM (69.4 %) was 
observed when analyzing the M. tuberculosis structure 
population of TB patient prison inmates in the city of 
Rio de Janeiro (2005 to 2006), with the second largest 
cluster composed of LAM2/SIT179 isolates, and one HR22. 
Increments in global LAM burdens may be associated to 
MDR and extensive MDR, thus indicating the molecular 
monitoring as an important tool to understand the distribution 
of the molecular structure of mycobacterial strains in this 
setting22. It is interesting to note that MDR belonging to the 
LAM2/SIT179 lineage in the present study was mainly drug 
resistant (Table 1), although 3’ IS6110-RFLP patterns were 
different from those of the prison study. This suggests the 
importance of combining genotyping methods in a high-
TB burden area of a closed environment, such as a tertiary 
hospital or prison. 
According to mathematical modeling studies, it is 
unlikely that drug-resistant isolates spread more easily than 
drug susceptible ones23. In this retrospective study, although 
no epidemiological relationship was detected regarding HR 
patients, the findings may imply that these cases may have 
resulted from recent transmission, possibly from the home 
environment and/or social network, including primary 
multidrug resistant strains, as only two of the patients infected 
with drug-resistant M. tuberculosis underwent previous 
treatment. Moreover, the data corroborate other studies 
suggesting that all-major circulating families are associated 
to resistance in a given geographic area24,25. In a recent report 
concerning strains isolated from Veracruz, Southeastern 
Mexico, the T lineage was predominant and 8/10 samples 
of the T1 sublineage were SIT 53 multidrug-resistant26. 
Similarly, 47% (27/58) of all drug resistant isolates detected 
in the present study belonged to the T superfamily, with T1 
contributing to most cases (22/27, 78.6%). It is intriguing that, 
despite the prevalence of the ubiquitous SIT 53/T1 prototype, 
the evolutionary SIT 535, comprised 70% of drug resistant 
strains (7/10) through the loss of three DR spaces. To the best 
of our knowledge, SIT 535 is not frequent in Brazil or in RJ 
in recent years20, although, as stated previously, genotyping 
studies are still scarce. Thus, this may suggest an endemic 
manner of transmission.
Table 3 - Characteristics of true-clustered tuberculous patients attended at the tertiary Pedro Ernesto University Hospital in Rio 
de Janeiro city, 1996 -1998
 
ID Age Sex Unity
Neigborhood/
Municipality
Data TB 
Diagnosis
DST Spoltype (SIT/sublineage) 3’ IS6110-RFLP 
pattern1
5’ IS6110-RFLP
 pattern
Epidemiological 
Remark
66
123
39
67
M
M
PN
WI
P. Miguel/
RJ##Andarai
5/20/199
11/21/1997
HR, EtR
 
(18/X2)  
Al, Sm, BCG, 
Born in PB, 
COPD, 
Born in RJ
55
56
51
65
M
M
WI
CM17
Nilopolis/RJ
P. Anchieta/RJ
04/16/1997
03/18/1997
EtR  (47/H1)   
DM, Al, Sm, 
born in RJ, 
hospital 
cupbearer 
DM, LC, DMS, 
Al, Sm, 
born in RJ 
Meet each 
other 
(Nosocomial) 
95
145
37
WI
F
M
HC
HC
Lins/RJ
Imbarie/DC
09/13/1997
06/17/1997 
S  (179/LAM2)  
BCG, 
born in RJ
ID: patient identification; SIT: shared international typing; RFLP: restriction fragment length polymorphism; M: male; F: female; PN: Pneumology Clinic; HC: Health Care; 
DST: drug susceptibility test; HR and EtR: isoniazid and ethionamide resistant; S: susceptible; MDR: resistant at least to isoniazid and rifampicin; N: no; Y: yes; WI: without 
information; PB: Paraiba State; BCG: Bacille Calmette Guèrin vaccine scar; Al: alcohol addict; Sm: smoker; COPD: Chronic obstructive pulmonary disease; RJ: Rio de 
Janeiro; DC: Duque de Caxias; DM: diabetes mellitus; LC: Laryngeal cancer; DMS: Dermatomyositis. 
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Another unusual genotype comprised high banding 
pattern X lineage strains. Unfortunately, the investigation 
of a mixed-clonal event in these patients was not possible, 
as only one culture sample was available, and both isolates 
did not grow in subcultures. However, recently Gonzalo-
Asensio et al.27 have described a direct correlation between 
Table 4 - Fingerprinting pattern of M. tuberculosis isolates from tertiary Pedro Ernesto University Hospital patients, grouped by 3’ 
IS6110-RFLP and subdivided according to the 5’ IS 6110-RFLP and the spoligotyping method. 
Molecular patterns by 
3’ IS6110-RFLP 5’ IS 6110-RFLP SPOLIGOTYPING
Number of 
clustered 
patients
(number of 
bands)
Number of 
clustered 
patients
(number of 
bands)
Number of 
clustered 
patients
SIT (LINEAGES)
2  
11
2  
16 0
 
SIT 75 (H3) 
 
SIT 50 (H3)
2  9 2
 
10 0
 
ORPHAN (T1) 
 
SIT 53 (T1)
4  
10
3 
0
 
16
 
10
2 
0
 
SIT179 (LAM2) 
 
SIT 50 (H3) 
 
SIT 53 (T1)
2  
10 0
 
15
 
16
0
 
SIT2508 (UD) 
 
SIT2557 (T1)
2  9 0
 
13
 
9
0
 
SIT 535 (T1) 
 
SIT1905 (T1)
2  
11
2  
16 0
 
SIT 1410 (Ud) 
 
SIT179 (LAM2)
5  
2
5  
4
2 
0 
0 
0
 
SIT 18 (X2) 
 
ORPHAN (T1) 
 
SIT137 (X2) 
 
NEW
2  
7
2  8 2
 
SIT47 (H1)
2  
10 2
 
10 0
 
SIT535 (T1) 
 
SIT1905 (T1)
2  
4
2  
4
0
 
SIT 1410 (Ud) 
 
SIT 535 (T1)
Ud:Undefined; SIT: Spoligotype international typing
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the normalized expression of IS6110 and the abundance of 
copies in MTBC chromosomes, including X lineage strains, 
varying from <5 to 14 copies. In this retrospective molecular 
analysis, although the gold standard 24 MIRU-VNTR 
method28 was not applied, the 3’ and 5’ IS6110-RFLP 
methods defined clusters comprising isolates from different 
geographic areas and were able to disclose differences in 
the restriction fragment size pattern up to additional six 
fragments (Table 4). Furthermore, a partial lack of genotypic 
cluster similarity was detected by all methods, leading to 
decreased cluster frequency, indicating that the results may 
reflect fractions of a possible recent transmission from 
different communities. The significant (p=0.046) cluster 
associations with HR may support this hypothesis. 
Recently, a one-year genotyping of M. tuberculosis 
isolated from the city of Porto, Portugal, by using 24 MIRU, 
found no evident chain of transmission of one or a limited 
number of specific genotypes29, a similar pattern to the 
HUPE strains observed herein, evidencing that multiple 
genotypes circulated in the urban area of Rio de Janeiro. 
Concerning the possible recent transmission episodes 
represented by HUPE clusters, no clear or classical 
epidemiological relationship could be established, as for the 
Porto study, suggesting a high genotypic structure diversity 
of M. tuberculosis circulating in the study area. 
The present study presents certain limitations. Firstly, 
old samples and inadequate storage led to the unsuccessful 
subculture of many resistant strains. In addition, the 
5’ IS6110-RFLP method was performed only among 
strains clustered by 3’ IS6110-RFLP. However, as proof 
of concept, this strategy was adequate. Finally, the study 
was carried out in a short timeframe, but this is justified 
by the fact that it is part of an earlier cross-sectional study. 
Despite this, and the fact that RFLP is more time-consuming 
and cumbersome than MIRU-VNTR, the RFLP method 
disclosed unsuspected and possibly transmitted infections 
aside from mixed infections, including for MDR strains. 
Immunodeficient and immunocompetent individuals may 
be infected with more than one strain during the same 
disease episode (mixed infection), or reinfected by a 
second M. tuberculosis strain during recurrent episodes 
(exogenous reinfection)30. Huyen et al.31 reported 3.1% of 
mixed infections by combining RFLP and spoligotyping in 
a rural area of Vietnam, equal frequency of our study, using 
both methods. Another study carried out a retrospective 
genotyping in previously samples suspected of having 
epidemiological relationships32, which in contrary to the 
present study, they described a slightly more adequate 
RFLP cluster results compared to MIRU-VNTR32,33. 
Additionally, RFLP lacks the discriminatory power for 
strains presenting less than six banding patterns, while 
spoligotyping and MIRU-VNTR are more adequate in this 
regard. Herein, only 2/7 low banding strains were clustered 
by all applied genotypic methods, displaying the same drug 
resistance, suggesting a possible transmission, although no 
epidemiological relationship was detected (Tables 3 and 4). 
According to Jonsson et al.32, clustering is an important 
finding, but not a crucial evidence of true relationships. 
In conclusion, despite being time-consuming, the 
3’ - 5’ IS6110-RFLP and spoligotyping techniques revealed 
an association risk and unsuspected past epidemiological 
events. In fact, the success of this study relies on available 
epidemiological data information. This study may, 
therefore, serve as a database for further evolutionary 
and characterization evaluation of circulating strains and, 
along with epidemiological data, may aid in more effective 
transmission control measures, mainly in close settings. 
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